<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">Ribavirin is metabolized by a reversible phosphorylation pathway or a degradative pathway involving de-ribosylation and amide hydrolysis [
 <xref ref-type="bibr" rid="CR39">39</xref>]. It does not inhibit cytochrome P450 enzymes. Therefore, there is minimal potential for P450 enzyme-based interactions. However, case reports showed that ribavirin has variable effects on warfarin dosing [
 <xref ref-type="bibr" rid="CR40">40</xref>]. The detailed mechanism has yet to be elucidated.
</p>
